Lu Li
Stock Analyst at UBS
(1.92)
# 3,167
Out of 5,152 analysts
15
Total ratings
66.67%
Success rate
1.06%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Lu Li
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| MYGN Myriad Genetics | Maintains: Neutral | $8 → $6 | $5.28 | +13.64% | 5 | Feb 24, 2026 | |
| QDEL QuidelOrtho | Maintains: Neutral | $31 → $35 | $21.19 | +65.17% | 4 | Jan 21, 2026 | |
| VCYT Veracyte | Maintains: Buy | $42 → $48 | $36.27 | +32.34% | 5 | Nov 5, 2025 | |
| FLGT Fulgent Genetics | Upgrades: Buy | $20 → $30 | $13.99 | +114.44% | 1 | Aug 5, 2025 |
Myriad Genetics
Feb 24, 2026
Maintains: Neutral
Price Target: $8 → $6
Current: $5.28
Upside: +13.64%
QuidelOrtho
Jan 21, 2026
Maintains: Neutral
Price Target: $31 → $35
Current: $21.19
Upside: +65.17%
Veracyte
Nov 5, 2025
Maintains: Buy
Price Target: $42 → $48
Current: $36.27
Upside: +32.34%
Fulgent Genetics
Aug 5, 2025
Upgrades: Buy
Price Target: $20 → $30
Current: $13.99
Upside: +114.44%